PEAK1

pseudopodium enriched atypical kinase 1

Basic information

Region (hg38): 15:77100656-77420144

Links

ENSG00000173517NCBI:79834OMIM:614248HGNC:29431Uniprot:Q9H792AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PEAK1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PEAK1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
143
clinvar
5
clinvar
148
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 143 6 0

Variants in PEAK1

This is a list of pathogenic ClinVar variants found in the PEAK1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-77114160-C-T not specified Uncertain significance (Dec 01, 2022)2356676
15-77114185-A-C not specified Uncertain significance (May 24, 2024)3305702
15-77114199-G-A not specified Uncertain significance (Feb 27, 2023)2489159
15-77114203-T-A not specified Uncertain significance (Jan 30, 2024)3211275
15-77114203-T-C not specified Uncertain significance (Jun 11, 2024)3305701
15-77114233-A-C not specified Uncertain significance (Sep 14, 2022)2311583
15-77114271-T-C not specified Uncertain significance (Sep 08, 2024)3416870
15-77114348-G-A PEAK1-related disorder Likely benign (May 15, 2019)3041452
15-77114383-C-T not specified Uncertain significance (Oct 06, 2023)3211274
15-77114422-C-T not specified Uncertain significance (Oct 29, 2024)2383010
15-77114449-G-C not specified Uncertain significance (Mar 20, 2024)3305707
15-77114482-G-C not specified Uncertain significance (Jun 05, 2024)2278535
15-77114505-C-A not specified Uncertain significance (Jan 23, 2023)2454337
15-77114505-C-T not specified Uncertain significance (Jan 14, 2025)3887702
15-77114621-C-T PEAK1-related disorder Likely benign (Mar 09, 2020)3057921
15-77114629-A-G not specified Uncertain significance (Aug 28, 2024)3416855
15-77114658-T-C not specified Uncertain significance (May 09, 2024)3305714
15-77114677-G-C not specified Uncertain significance (May 24, 2024)3305716
15-77114678-G-A PEAK1-related disorder Likely benign (May 15, 2019)3041497
15-77114683-G-A not specified Uncertain significance (Nov 13, 2024)3416878
15-77114798-G-C PEAK1-related disorder Likely benign (Aug 28, 2019)3052438
15-77114812-G-C not specified Uncertain significance (Oct 09, 2024)3416872
15-77114838-T-C not specified Uncertain significance (Sep 03, 2024)3416854
15-77114846-T-C Likely benign (Mar 01, 2023)2645589
15-77114860-T-A not specified Uncertain significance (Aug 04, 2024)3416858

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PEAK1protein_codingprotein_codingENST00000560626 4312016
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0008680.9991247660451248110.000180
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1779409251.020.000049811517
Missense in Polyphen358367.330.974614534
Synonymous1.183093360.9180.00001713471
Loss of Function4.961757.70.2950.00000396682

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002780.000278
Ashkenazi Jewish0.0003980.000397
East Asian0.0004470.000445
Finnish0.00004640.0000464
European (Non-Finnish)0.0001950.000177
Middle Eastern0.0004470.000445
South Asian0.00006540.0000654
Other0.0003300.000330

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable catalytically inactive kinase. Scaffolding protein that regulates the cytoskeleton to control cell spreading and migration by modulating focal adhesion dynamics (PubMed:23105102, PubMed:20534451). Acts as a scaffold for mediating EGFR signaling (PubMed:23846654). {ECO:0000269|PubMed:20534451, ECO:0000269|PubMed:23105102, ECO:0000269|PubMed:23846654}.;

Intolerance Scores

loftool
rvis_EVS
-1.29
rvis_percentile_EVS
5

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.756
ghis
0.574

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Peak1
Phenotype

Gene ontology

Biological process
protein phosphorylation;cell migration;peptidyl-tyrosine phosphorylation;substrate adhesion-dependent cell spreading;protein autophosphorylation;focal adhesion assembly;regulation of focal adhesion assembly
Cellular component
cytoplasm;focal adhesion;actin cytoskeleton
Molecular function
protein kinase activity;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding;identical protein binding